Brand vs. Authorized Generic

Natroba™ (Spinosad) is the brand name and Spinosad Topical Suspension is the authorized generic version. Both are widely covered by Medicaid and insurance plans.

For commercial insurance patients, always prescribe Spinosad Topical Suspension.

For Medicaid patients, refer to your state PDL and prescribe either Natroba™ or Spinosad Topical Suspension authorized generic accordingly.

Targeted topical mechanism of action

Unlike neurotoxic agents that are systemically absorbed, the Natroba™ (Spinosad) formulation delivers the active compound (Spinosad) to the stratum corneum, and does not penetrate deep into the dermis or enter into the systemic circulation.2

Explore the MOA

New standard for efficacy

Natroba™ (Spinosad) has demonstrated it can resolve all clinical signs and symptoms of scabies, which can be confirmed via microscope and dermoscope.1

See the efficacy data

Safety for today’s patient-directed care

Natroba™ (Spinosad) demonstrated favorable tolerability in Phase III clinical trials, with minimal adverse reactions reported including application site irritation (2/0.7%) and dry skin (1/0.3%).1

See the safety data

There is no known published data documenting resistance to the active compound, Spinosad, in scabies mites.4

Formulary Finder

This tool helps you quickly confirm insurance coverage.

Look up Natroba™ (Spinosad) online

Need Local Support?

Request a virtual or in-person visit with a Cipher Representative to answer product or treatment questions, and assist with practice tools.

Request a rep visit